bohemine and olomoucine ii

bohemine has been researched along with olomoucine ii in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Havlícek, L; Krystof, V; Kuzma, M; Lenobel, R; Strnad, M1
Bravo-Altamirano, K; DeStefino, NR; Liang, M; Mazzarisi, CM; Meriney, SD; Olszewski, RA; Rensch, G; Swanson, L; Tarr, TB; Valdomir, G; Wilson, GM; Wipf, P1
Bazgier, V; Berka, K; Gucký, T; Havlíček, L; Jaffe, CL; Jorda, R; Kryštof, V; Nasereddin, A; Popa, A; Popa, I; Řezníčková, E; Strnad, M; Zatloukal, M1

Other Studies

3 other study(ies) available for bohemine and olomoucine ii

ArticleYear
Synthesis and biological activity of olomoucine II.
    Bioorganic & medicinal chemistry letters, 2002, Nov-18, Volume: 12, Issue:22

    Topics: Antineoplastic Agents; CDC2 Protein Kinase; CDC28 Protein Kinase, S cerevisiae; Cell Survival; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Kinetin; Purines; Roscovitine; Structure-Activity Relationship; Tumor Cells, Cultured

2002
Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist.
    ACS medicinal chemistry letters, 2012, Dec-13, Volume: 3, Issue:12

    Topics:

2012
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.
    Bioorganic & medicinal chemistry letters, 2015, Jun-01, Volume: 25, Issue:11

    Topics: Antiprotozoal Agents; Binding Sites; Leishmania donovani; Leishmania major; Models, Molecular; Molecular Structure; Protein Binding; Protein Conformation; Proto-Oncogene Proteins c-crk; Purines; Structure-Activity Relationship

2015